Abstract:Misfolding of the prion protein (PrP) and templating of its pathological conformation onto cognate proteins causes a number of lethal disorders of central nervous system in humans and animals, such as Creutzfeldt‐Jacob disease, chronic wasting disease and bovine spongiform encephalopathy. Structural rearrangement of PrPC into PrPSc promotes aggregation of misfolded proteins into β‐sheet‐rich fibrils, which can be visualized by conformationally‐sensitive fluorescent probes. Early detection of prion misfolding and deposition might provide useful insights into its pathophysiology. Pentameric formyl thiophene acetic acid (pFTAA) is a novel amyloid probe that was shown to sensitively detect various misfolded proteins, including PrP. Here, we compare sensitivity of pFTAA staining and spectral microscopy with conventional methods of prion detection in mouse brains infected with mouse‐adapted 22L prions. pFTAA bound to prion deposits in mouse brain sections exhibited a red‐shifted fluorescence emission spectrum which quantitatively increased with disease progression. Small prion deposits were detected as early as 50 days post‐inoculation (DPI), well before appearance of clinical signs. Moreover, we detected significant spectral shifts in the greater brain parenchyma as early as 25 DPI, rivaling the most sensitive conventional method (real‐time quaking‐induced conversion). These results showcase the potential of pFTAA staining combined with spectral imaging for screening of prion‐infected tissue. Not only does this method have comparable sensitivity to established techniques, it is faster and technically simpler. Finally, this readout provides valuable information about the spatial distribution of prion aggregates across tissue in the earliest stages of infection, potentially providing valuable pathophysiological insight into prion transmission.

Spectral Fluorescence Pathology of Protein Misfolding Disorders

Recent Advances in Fluorescent Probes Development for Interrogating Protein Misfolding and Aggregation

Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics

Mechanisms and pathology of protein misfolding and aggregation

Advanced Techniques for Detecting Protein Misfolding and Aggregation in Cellular Environments

Probing the Molecular Structure and Dynamics of Membrane‐Bound Proteins during Misfolding Processes by Sum‐Frequency Generation Vibrational Spectroscopy

Analysis of Protein Conformational Strains-A Key for New Diagnostic Methods of Human Diseases

Early detection of prion protein aggregation with a fluorescent pentameric oligothiophene probe using spectral confocal microscopy

Profiling the Misfolded Proteome in Human Disease

Exploration and Application of Chemico-Biology Detection Methods and Patterns for Factors Inducing Protein Misfolding

Fluorogenic Toolbox for Visualizing Protein Aggregation: from Designing Principles to Biological Application

Techniques for monitoring protein misfolding and aggregation in vitro and in living cells

Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications

Single-molecule approaches to prion protein misfolding.

Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases

Interrogating Amyloid Aggregation with Aggregation-Induced Emission Fluorescence Probes.

Misfolding and Interactions of Aß Proteins: Insight from Single Molecule Experiments and Computational Analyses

Fluorescence Lifetime-Assisted Probing of Protein Aggregation with sub-Organellar Resolution

Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways

Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly

Thermodynamic and kinetic approaches for drug discovery to target protein misfolding and aggregation